) indexes are set for their annual reconstitution, scheduled to take place after Friday's closing bell. Indrani De, FTSE Russell's head of global investment research, joins Catalysts to provide insights into this event.
And in terms of industry, we are having so much innovation in the technology sector and health care, particularly biotech. So just like the markets on a macro backdrop, we are constantly talking about rates and growth, and similarly, in terms of a secular driver, A. I today is almost like what the Internet did in the 19 nineties.Initially, it starts in a certain part of the economy, and then it broadens out.The names that are coming into Russell 1000, many of them are a I related A I play kind of thing.
And since that joining and I think that that's just an example, that points to some of the concern with some of these tech names that a lot of investors have right, that there's this hype cycle and then the bad earnings print.It is the whole process.Like since the rank day on April 30th through May through June, leading up to the actual reconstitution, we put out the preliminary names.
For so much of the movement that we've seen and also brought waiting here on the indexes, you are very correct that we have an enormous amount of concentration that is going on. However, I do believe as the A I story leads to more productivity gains and it spreads out across the economy, this concentration thing may abate a little bit simply because of the widening out of this productivity thing.If you're tired of coming across the same dividend stocks over and again, here's one analysts love that provides a high yield and a cheap share price. The post 9.